News & Updates
Showing Infectious Diseases articles
Showing

Nirmatrelvir conferred protection in older adults during the Omicron outbreak
During the surge of the Omicron (B.1.1.529) variant, antiviral therapy with nirmatrelvir significantly reduced the rate of COVID-19-related hospitalization or death among patients aged ≥65 years, according to a recent study.
Nirmatrelvir conferred protection in older adults during the Omicron outbreak
13 Sep 2022
3D-printed masks a good alternative to N95 respirators
Reusable 3D-printed respirators offer a cost-effective alternative to N95 masks in providing protection against respiratory pathogens, such as SARS-CoV-2, suggests a recent study. In addition, fit testing results show that some 3D-printed mask designs appear to exceed the fit of N95 masks.
3D-printed masks a good alternative to N95 respirators
12 Sep 2022
COVID-19 lockdown weakens metabolism in people with glucose intolerance
In Japan, the declaration of a state of emergency in response to the COVID-19 pandemic led to negative metabolic consequences in people with glucose intolerance, such as lowered skeletal muscle and increased body weight and body fat, a recent study has found.
COVID-19 lockdown weakens metabolism in people with glucose intolerance
10 Sep 2022
IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients
All intravenous (IV) and subcutaneous (SC) doses of the monoclonal antibody combination of casirivimab plus imdevimab effectively reduces viral load in COVID-19 patients with asymptomatic or low-risk symptomatic infection, according to the results of a phase II study.
IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients
07 Sep 2022
Pandemic-fueled psych problems, fear of recurrence common among cancer patients
Psychological problems, such as post-traumatic stress disorder (PTSD), depression, and anxiety, are common among cancer patients during the COVID-19 pandemic, as were fears of disease progression or recurrence, a recent study has found.
Pandemic-fueled psych problems, fear of recurrence common among cancer patients
02 Sep 2022
Could tixagevimab–cilgavimab prevent progression to severe COVID-19 in unvaccinated adults?
The combination of tixagevimab and cilgavimab, two SARS-CoV-2 neutralizing monoclonal antibodies, appeared to protect against progression to severe disease or death in non-hospitalized, unvaccinated adults presenting with mild-to-moderate COVID-19, results of the ongoing phase III TACKLE trial showed.
Could tixagevimab–cilgavimab prevent progression to severe COVID-19 in unvaccinated adults?
01 Sep 2022
Do eyeglasses act as a shield against SARS-CoV-2 infection? Maybe—or maybe not
There is inconclusive evidence that wearing one’s eyeglasses can lower their chances of contracting COVID-19, according to a recent study.


